The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …
leading causes of chronic liver disease worldwide. NAFLD and ALD share …
Pathophysiological aspects of alcohol metabolism in the liver
J Hyun, J Han, C Lee, M Yoon, Y Jung - International journal of molecular …, 2021 - mdpi.com
Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic
or binge consumption of alcohol. The liver is the major organ that metabolizes alcohol; …
or binge consumption of alcohol. The liver is the major organ that metabolizes alcohol; …
Microbiome-derived ethanol in nonalcoholic fatty liver disease
AS Meijnikman, M Davids, H Herrema, O Aydin… - Nature medicine, 2022 - nature.com
To test the hypothesis that the gut microbiota of individuals with nonalcoholic fatty liver
disease (NAFLD) produce enough ethanol to be a driving force in the development and …
disease (NAFLD) produce enough ethanol to be a driving force in the development and …
Convergent somatic mutations in metabolism genes in chronic liver disease
SWK Ng, FJ Rouhani, SF Brunner, N Brzozowska… - Nature, 2021 - nature.com
The progression of chronic liver disease to hepatocellular carcinoma is caused by the
acquisition of somatic mutations that affect 20–30 cancer genes,,,,,,–. Burdens of somatic …
acquisition of somatic mutations that affect 20–30 cancer genes,,,,,,–. Burdens of somatic …
Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Its
worldwide prevalence is rapidly increasing and is currently estimated at 24%. NAFLD is …
worldwide prevalence is rapidly increasing and is currently estimated at 24%. NAFLD is …
Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …
Reverse pharmacology of Nimbin-N2 attenuates alcoholic liver injury and promotes the hepatoprotective dual role of improving lipid metabolism and downregulating …
G Sudhakaran, P Prathap, A Guru… - Molecular and cellular …, 2022 - Springer
Alcoholic liver disease is one of the most prominent liver diseases in the world. Lipid
accumulation accompanied by oxidative stress and inflammation in the liver is the most …
accumulation accompanied by oxidative stress and inflammation in the liver is the most …
Severe hypertriglyceridemia: existing and emerging therapies
WA Malick, R Do, RS Rosenson - Pharmacology & Therapeutics, 2023 - Elsevier
Severe hypertriglyceridemia (sHTG), defined as a triglyceride (TG) concentration≥ 500
mg/dL (≥ 5.7 mmol/L) is an important risk factor for acute pancreatitis. Although lifestyle …
mg/dL (≥ 5.7 mmol/L) is an important risk factor for acute pancreatitis. Although lifestyle …
Understanding NAFLD: from case identification to interventions, outcomes, and future perspectives
D Clayton-Chubb, W Kemp, A Majeed, JS Lubel… - Nutrients, 2023 - mdpi.com
While non-alcoholic fatty liver disease (NAFLD) is a prevalent and frequent cause of liver-
related morbidity and mortality, it is also strongly associated with cardiovascular disease …
related morbidity and mortality, it is also strongly associated with cardiovascular disease …
Effect of natural polysaccharides on alcoholic liver disease: A review
S Li, X Zhou, R Chen, Q Zhang, Y Sun… - International Journal of …, 2023 - Elsevier
In this study, we systematically collected relevant literature in the past five years on the
intervention of natural polysaccharides in alcoholic liver disease (ALD) and reviewed the …
intervention of natural polysaccharides in alcoholic liver disease (ALD) and reviewed the …